Steven Cohen Veracyte, Inc. Transaction History
Point72 Asset Management, L.P.
- $40.1 Billion
- Q1 2025
A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Veracyte, Inc. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 25,159 shares of VCYT stock, worth $669,480. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25,159
Previous 523,162
95.19%
Holding current value
$669,480
Previous $20.7 Million
96.4%
% of portfolio
0.0%
Previous 0.05%
Shares
14 transactions
Others Institutions Holding VCYT
# of Institutions
306Shares Held
79.1MCall Options Held
15.5KPut Options Held
16.7K-
Vanguard Group Inc Valley Forge, PA8.26MShares$220 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.79MShares$207 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI5.24MShares$139 Million0.27% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl3.94MShares$105 Million1.26% of portfolio
-
Wellington Management Group LLP Boston, MA3.85MShares$103 Million0.02% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $1.9B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...